Cargando…
Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT)
Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994056/ https://www.ncbi.nlm.nih.gov/pubmed/35415025 http://dx.doi.org/10.7759/cureus.23011 |
_version_ | 1784684028832514048 |
---|---|
author | Noor, Syed Shahid Najjad, Muhammad Kazim Ahmed, Nasir Anwar, Khurram Memon, Abdul Riaz, Tehseen Hanif, Muhammad Maqbool, Nauman Ahmed, Saeed Ahmed, Israr Khanzada, Ali Yasir |
author_facet | Noor, Syed Shahid Najjad, Muhammad Kazim Ahmed, Nasir Anwar, Khurram Memon, Abdul Riaz, Tehseen Hanif, Muhammad Maqbool, Nauman Ahmed, Saeed Ahmed, Israr Khanzada, Ali Yasir |
author_sort | Noor, Syed Shahid |
collection | PubMed |
description | Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response of Nuberol Forte® (paracetamol 650 mg + orphenadrine 50 mg) to musculoskeletal pain in routine Pakistani practice and its impact on improving the patient’s QoL. Methods A prospective, observational multicenter study (NFORT-EFFECT: Safety & Efficacy of Nuberol Forte in Pain Management). Three hundred ninety-nine patients with known prescreened musculoskeletal pain were recruited from 10 major healthcare facilities across six (6) major cities of Pakistan, as per the inclusion/exclusion criteria. After the baseline visit (Visit 1), the patients were followed up one to two weeks (Visit 2) after the treatment as per the physician's discretion. Data were collected using the Case Report Form (CRF) designed for the study, and adverse events (AEs) were also monitored to assess drug safety. Pain intensity was assessed through a visual analog scale (VAS), and QoL was assessed using the Muscle and Joint Measure (MJM) scale. Results Out of 399 enrolled patients, 49.4% were males and 50.6% were females with a mean age of 47.24 ± 14.20 years. Most patients were presented with knee osteoarthritis (OA), i.e., 148 (38%), followed by backache 70 (18.2%). A significant reduction in the mean pain score was observed after treatment with the combination of paracetamol and orphenadrine (p<0.05). Furthermore, an overall improvement in the patient’s QoL was also observed. During the study, only 10 patients reported mild adverse events (AEs), namely, dryness of the mouth, dizziness, gastric irritation, tachycardia, restlessness, etc. Conclusion The combination of paracetamol and orphenadrine (Nuberol Forte) exhibited effective pain management among patients with musculoskeletal conditions and improved their QoL. |
format | Online Article Text |
id | pubmed-8994056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-89940562022-04-11 Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) Noor, Syed Shahid Najjad, Muhammad Kazim Ahmed, Nasir Anwar, Khurram Memon, Abdul Riaz, Tehseen Hanif, Muhammad Maqbool, Nauman Ahmed, Saeed Ahmed, Israr Khanzada, Ali Yasir Cureus Pain Management Background Musculoskeletal pain is the most common complaint presented to the health practitioner. It is well-known that untreated or under-treated pain can have a significant negative impact on an individual’s quality of life (QoL). Objectives The current study aimed to assess the clinical response of Nuberol Forte® (paracetamol 650 mg + orphenadrine 50 mg) to musculoskeletal pain in routine Pakistani practice and its impact on improving the patient’s QoL. Methods A prospective, observational multicenter study (NFORT-EFFECT: Safety & Efficacy of Nuberol Forte in Pain Management). Three hundred ninety-nine patients with known prescreened musculoskeletal pain were recruited from 10 major healthcare facilities across six (6) major cities of Pakistan, as per the inclusion/exclusion criteria. After the baseline visit (Visit 1), the patients were followed up one to two weeks (Visit 2) after the treatment as per the physician's discretion. Data were collected using the Case Report Form (CRF) designed for the study, and adverse events (AEs) were also monitored to assess drug safety. Pain intensity was assessed through a visual analog scale (VAS), and QoL was assessed using the Muscle and Joint Measure (MJM) scale. Results Out of 399 enrolled patients, 49.4% were males and 50.6% were females with a mean age of 47.24 ± 14.20 years. Most patients were presented with knee osteoarthritis (OA), i.e., 148 (38%), followed by backache 70 (18.2%). A significant reduction in the mean pain score was observed after treatment with the combination of paracetamol and orphenadrine (p<0.05). Furthermore, an overall improvement in the patient’s QoL was also observed. During the study, only 10 patients reported mild adverse events (AEs), namely, dryness of the mouth, dizziness, gastric irritation, tachycardia, restlessness, etc. Conclusion The combination of paracetamol and orphenadrine (Nuberol Forte) exhibited effective pain management among patients with musculoskeletal conditions and improved their QoL. Cureus 2022-03-09 /pmc/articles/PMC8994056/ /pubmed/35415025 http://dx.doi.org/10.7759/cureus.23011 Text en Copyright © 2022, Noor et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Pain Management Noor, Syed Shahid Najjad, Muhammad Kazim Ahmed, Nasir Anwar, Khurram Memon, Abdul Riaz, Tehseen Hanif, Muhammad Maqbool, Nauman Ahmed, Saeed Ahmed, Israr Khanzada, Ali Yasir Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title | Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title_full | Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title_fullStr | Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title_full_unstemmed | Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title_short | Clinical Response of Nuberol Forte® for Pain Management With Musculoskeletal Conditions in Routine Pakistani Practice (NFORTE-EFFECT) |
title_sort | clinical response of nuberol forte® for pain management with musculoskeletal conditions in routine pakistani practice (nforte-effect) |
topic | Pain Management |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994056/ https://www.ncbi.nlm.nih.gov/pubmed/35415025 http://dx.doi.org/10.7759/cureus.23011 |
work_keys_str_mv | AT noorsyedshahid clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT najjadmuhammadkazim clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT ahmednasir clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT anwarkhurram clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT memonabdul clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT riaztehseen clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT hanifmuhammad clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT maqboolnauman clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT ahmedsaeed clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT ahmedisrar clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect AT khanzadaaliyasir clinicalresponseofnuberolforteforpainmanagementwithmusculoskeletalconditionsinroutinepakistanipracticenforteeffect |